![David Baker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Baker
Directeur/Bestuurslid bij
GRI BIO, INC.
Vermogen: - $ op 30-06-2026
Profiel
David C.
Baker was the founder of Vallon Pharmaceuticals, Inc., founded in 2018, where the title held was Director in 2023.
Current jobs include Chairman at Philadelphia Education Fund, Director at Benchworks, Inc., and Independent Director at GRI Bio, Inc. since 2019.
Former jobs include President & Chief Executive Officer at Alcobra Ltd. in 2017, Independent Director at Devonian Health Group, Inc. from 2024 to 2026, and Vice President-Commercial Strategy & New Business at Shire Pharmaceuticals, Inc. from 2004 to 2013.
Education history includes undergraduate studies at Duke University and an MBA from The Fuqua School of Business.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
GRI BIO, INC. -.--% | 17-01-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
| 22-01-2026 | 0 ( -.--% ) | - $ | 30-06-2026 |
Actieve functies van David Baker
| Bedrijven | Functie | Begin |
|---|---|---|
| GRI BIO, INC. | Directeur/Bestuurslid | 15-01-2019 |
Philadelphia Education Fund
 Philadelphia Education Fund The Philadelphia Education Fund (PEF) is a nonprofit organization founded in 1985 that focuses on expanding educational and career opportunities for primarily low-income, first-generation college-bound students. The non-profit company is based in Philadelphia, PA. The organization provides resources, expertise, and programs supporting college access, career readiness, STEM education, and postsecondary success. PEF serves over 3,000 students annually through initiatives such as the College Access Program, the Scholars Program, and middle grades programs like Spark, which introduce students to various career pathways. The organization leads the STEM Ecosystem, a collaborative network that connects schools, universities, businesses, and government to promote equitable STEM education and workforce development, with efforts like the STEM Equity Collective aimed at increasing participation among underrepresented groups. Additional programs support foster youth college readiness and offer professional development for educators. PEF partners with corporate, civic, and educational entities, hosts community engagement events, and provides online resources to increase access to college counseling. The CEO of the company is Farah M. Jimenez. | Voorzitter | - |
Benchworks, Inc.
 Benchworks, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing services | Directeur/Bestuurslid | - |
Eerdere bekende functies van David Baker
| Bedrijven | Functie | Einde |
|---|---|---|
| DEVONIAN HEALTH GROUP INC. | Voorzitter | 03-06-2024 |
| GRI BIOPAR | Algemeen Directeur | 21-04-2023 |
Alcobra Ltd.
 Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Algemeen Directeur | 01-11-2017 |
Shire Pharmaceuticals, Inc.
 Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01-12-2013 |
Opleiding van David Baker
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
32
Eerstegraads connecties
9
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 9 |
|---|---|
Alcobra Ltd.
Alcobra Ltd. Pharmaceuticals: MajorHealth Technology Develops proprietary pharmaceutical products | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shire Pharmaceuticals, Inc.
Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Philadelphia Education Fund
Philadelphia Education Fund The Philadelphia Education Fund (PEF) is a nonprofit organization founded in 1985 that focuses on expanding educational and career opportunities for primarily low-income, first-generation college-bound students. The non-profit company is based in Philadelphia, PA. The organization provides resources, expertise, and programs supporting college access, career readiness, STEM education, and postsecondary success. PEF serves over 3,000 students annually through initiatives such as the College Access Program, the Scholars Program, and middle grades programs like Spark, which introduce students to various career pathways. The organization leads the STEM Ecosystem, a collaborative network that connects schools, universities, businesses, and government to promote equitable STEM education and workforce development, with efforts like the STEM Equity Collective aimed at increasing participation among underrepresented groups. Additional programs support foster youth college readiness and offer professional development for educators. PEF partners with corporate, civic, and educational entities, hosts community engagement events, and provides online resources to increase access to college counseling. The CEO of the company is Farah M. Jimenez. | |
Benchworks, Inc.
Benchworks, Inc. Miscellaneous Commercial ServicesCommercial Services Provides marketing services | Commercial Services |
The Fuqua School of Business
 The Fuqua School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Devonian Health Group, Inc.
 Devonian Health Group, Inc. Pharmaceuticals: MajorHealth Technology Develops botanical drugs | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
GRI Bio, Inc.
 GRI Bio, Inc. BiotechnologyHealth Technology Develops therapies for the treatment of inflammatory, fibrotic and autoimmune diseases | Health Technology |
Kies MarketScreener 
